NED
GILD icon

Nancy E. Dempze’s Gilead Sciences GILD Stock Holding History

Nancy E. Dempze’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-5,210
Closed -$402K – 68
2018
Q3 		$402K Sell
5,210
-2,956
-36% -$223K 0.45% 49
2018
Q2 		$579K Buy
8,166
+598
+8% +$42.2K 0.71% 35
2018
Q1 		$570K Buy
7,568
+83
+1% +$6.6K 0.7% 39
2017
Q4 		$536K Sell
7,485
-103
-1% -$7.82K 0.65% 42
2017
Q3 		$615K Sell
7,588
-780
-9% -$59.6K 0.87% 38
2017
Q2 		$592K Sell
8,368
-2,502
-23% -$166K 0.85% 39
2017
Q1 		$738K Sell
10,870
-50
-0.5% -$3.52K 1.13% 33
2016
Q4 		$782K Sell
10,920
-500
-4% -$37.2K 1.37% 26
2016
Q3 		$903K Buy
11,420
+969
+9% +$78.7K 1.58% 23
2016
Q2 		$873K Buy
10,451
+3,348
+47% +$297K 1.55% 23
2016
Q1 		$653K Buy
7,103
+1,301
+22% +$117K 1.15% 30
2015
Q4 		$587K Buy
+5,802
New +$604K 1.13% 32

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Nancy E. Dempze's GILD Position: Q4 2018 in Review

Nancy E. Dempze sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 5,210 shares — an estimated $402K sold.

Nancy E. Dempze first reported a position in GILD in Q4 2015 and held it in 12 quarters. The position peaked at $903K in Q3 2016. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Nancy E. Dempze reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Nancy E. Dempze sold 5,210 Gilead Sciences shares in Q4 2018, an estimated $402K.
  • Nancy E. Dempze first reported a position in Gilead Sciences in Q4 2015 and held it in 12 quarters.
  • Nancy E. Dempze's Gilead Sciences position peaked at $903K in Q3 2016.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Nancy E. Dempze's 13F filing for Q4 2018, filed 24 Jan 2019.